Encompass Health Corp traded at $107.31 this Monday March 9th, increasing $0.36 or 0.34 percent since the previous trading session. Looking back, over the last four weeks, Encompass Health gained 1.55 percent. Over the last 12 months, its price rose by 8.27 percent. Looking ahead, we forecast Encompass Health Corp to be priced at 103.72 by the end of this quarter and at 94.60 in one year, according to Trading Economics global macro models projections and analysts expectations.
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.